Related projects
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Parkinson’s disease (PD) is the 2nd most common neurodegenerative disorder, affecting greater than 1% of people over 60. As occurrences are predicted to double in the next 20 years, there is a critical need for the development of prophylactic and/or therapeutic interventions. We have recently identified two enzymes, USP8 and AMPK, that interact and may be involved in mechanisms that lead to the onset and progression of PD. In collaboration with the Parkinson’s Society Southwestern Ontario (PSSO), the interaction of USP8 and AMPK will be explored to determine if they are directly involved in PD or associated cellular mechanisms. The research proposed will add to the growing list of potential therapeutic targets for the fight against this debilitating disease.
Yufeng Tong
Parkinson Society Southwestern Ontario
Life Sciences
Other services (except public administration)
University of Windsor
Accelerate
Discover more projects across a range of sectors and discipline — from AI to cleantech to social innovation.
Find the perfect opportunity to put your academic skills and knowledge into practice!
Find ProjectsThe strong support from governments across Canada, international partners, universities, colleges, companies, and community organizations has enabled Mitacs to focus on the core idea that talent and partnerships power innovation — and innovation creates a better future.